TRAVERE THERAPEUTICS INC (TVTX)
US89422G1076 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to TVTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.9. This target is 19.98% above the current price.
TVTX was analyzed by 22 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about TVTX.
In the previous month the buy percentage consensus was at a similar level.
TVTX was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-01 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-11-01 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-21 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-10-16 | ScotiaBank | Initiate | Sector Outperform |
| 2024-10-11 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-10-09 | Guggenheim | Maintains | Buy -> Buy |
| 2024-10-09 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-10-09 | B of A Securities | Maintains | Buy -> Buy |
| 2024-10-08 | Leerink Partners | Reiterate | Outperform -> Outperform |
| 2024-10-01 | Barclays | Maintains | Overweight -> Overweight |
| 2024-09-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-27 | Guggenheim | Maintains | Buy -> Buy |
| 2024-09-27 | B of A Securities | Maintains | Buy -> Buy |
| 2024-09-27 | Citigroup | Maintains | Buy -> Buy |
| 2024-09-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-09-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-09 | Guggenheim | Upgrade | Neutral -> Buy |
| 2024-09-06 | B of A Securities | Maintains | Buy -> Buy |
| 2024-09-06 | Citigroup | Maintains | Buy -> Buy |
| 2024-09-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-02 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-02 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-08-02 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-05-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |